Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05151965

Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability

Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability (AGHI)

Status
Recruiting
Phase
Study type
Observational
Enrollment
72 (estimated)
Sponsor
Panam Clinic · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective cohort study is to compare patient-reported, clinical, and functional outcomes in patients who have elected to have either the Bankart with Remplissage or Latarjet procedure for the treatment of anterior glenohumeral instability (AGHI) up to 24-months postoperative.

Detailed description

The purpose of this prospective cohort study is to compare patient-reported, clinical, and functional outcomes in patients who have elected to have either the Bankart with Remplissage or Latarjet procedure for the treatment of AGHI up to 24-months postoperative. A secondary objective aims to address rates of return to sport (RTS) and performance in an RTS assessment in athletic patients with anterior glenohumeral instability (AGHI) who elect to undergo either surgical intervention until 24-months postoperative.

Conditions

Interventions

TypeNameDescription
PROCEDUREBankart Repair and RemplissageArthroscopic Bankart repair with a minimum of 3 anchors 1 or 2 anchor Remplissage subsequently performed with percutaneous anchor insertion in the base of the Hill-Sachs defect, and sutures passed in a horizontal mattress configuration 1 cm apart, tied in the subacromial space.
PROCEDURELatarjet Coracoid TransferCoracoid transfer performed via deltopectoral approach with horizontal subscapularis split. Graft placed in the conventional orientation, secured with 2 screws, ensuring the graft is not lateral to the glenoid rim.

Timeline

Start date
2022-09-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2021-12-09
Last updated
2024-04-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05151965. Inclusion in this directory is not an endorsement.